, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Cost of Sales Cost of sales of the Company and its subsidiaries soared year-on-year by Baht 32.35 million or 25.87% to Baht
375.89 100.00 317.58 100.00 - - Cost of Sales Cost of sales of the Company and its subsidiaries soared year-on-year by Baht 32.35 million or 25.87% to Baht 157.39 million in 2019 in line with growth in
as the Company allocated more sales to Australian zone. Therefore, the export sales to Australian zone rose from Baht 29 million in 2017 to Baht 139 million in this year or soared for more than 374
increased in export sales in Asian and The Middle East zones by Baht 138 million or increased by 17%. In prior year, these zones are facing economic problems. However, in this year, the sales soared as the
several customers in the zones since the Company would like to collect overdue balance from the customers first. However, in this year, the sales soared as the economy is getting better and there is a
zones since the Company would like to collect overdue balance from the customers first. However, in this year, the sales soared as the economy is getting better and there is a higher demand of automotive
export sales in Asian and The Middle East zones by Baht 121 million or increased by 31%. In prior year, these zones are facing economic problems. However, in this year, the sales soared as the economy is
million in this period or soared for more than 354%, which is mainly from sales of OEM parts of Mazda cars. Selling and Administrative Expenses In the three-month period ended 30 September 2018, the
year, the sales soared as the economy is getting better and there is a higher demand of automotive parts in the country. Moreover, the domestic sales increased from Baht 77 million in Quarter 3 2018 to